MGA Report Featured by The Center for Biosimilars
On Thursday, The Center for Biosimilars, a sister site of The American Journal of Managed Care, published an article discussing the differences between the patent systems in the United States and Europe when it comes to biosimilars. The article featured the latest report released by MGA, and authored by Alex Brill and Christy Robinson, titled “How Patent Thickets Constrain the US Biosimilars Market and Domestic Manufacturing”:
The patent system in the United States differs markedly from that in the European Union, where biosimilar developers can challenge patents with far greater ease and less expense, according to a report from Matrix Global Advisors, a public policy consulting firm.
Read the article here.
Read the MGA report here.